My two top bets are expected to have a mixed approach. One would be from a defensive space; i.e., Pharma. I am bullish on Lupin. The stock is under sideways consolidation and has been extremely …
Chartist Talks: Milan Vaishnav explains why he is bullish on Lupin, ITC for November series
view original post